What we do
KS-V Peptide's proprietary drug discovery and development platform, KPDS™, is designed to discover peptide molecules with high binding and specificity to target proteins or cells, and we are structured to drive three types of innovative peptide-centric therapies:

(1) Peptide and oral peptidomimetic drug molecules
(2) Peptide targeted drug conjugate (PDC & RDC)
(3) Precision Nucleic Acid Drug Delivery with CP-LNP (Cyclic Peptide Conjugated Lipid Nanoparticles)
China Hefei KS-V Peptide Biological Technology Co.Ltd
What we do
KS-V Peptide's proprietary drug discovery and development platform, KPDS™, is designed to discover peptide molecules with high binding and specificity to target proteins or cells, and we are structured to drive three types of innovative peptide-centric therapies:
(1) Peptide and oral peptidomimetic drug molecules
(2) Peptide targeted drug conjugate (PDC & RDC)
(3) Precision Nucleic Acid Drug Delivery with CP-LNP (Cyclic Peptide Conjugated Lipid Nanoparticles)
China Hefei KS-V Peptide Biological Technology Co.Ltd
PRODUCT AND SERVICE
R&D TEAM AND TECHNOLOGY
  • Our team

  • Process platform

  • Service

  • Packaging technology

  • More than 30 PhD level research and development team
    KS-V Peptide has a doctoral-level R&D team of more than 30 people. The team members are from pharmaceutical companies and have many years of experience in drug development.
    Many years of service experience in peptide synthesis
    The management team has rich experience in innovative drug research and development and technical services, and has many years of experience in peptide synthesis services to assist in the preparation and process development of difficult peptides.
    More than 10 years of experience in polypeptide drug process development
    The team has more than 10 years of experience in peptide drug process development to ensure the economy, robustness and repeatability of the process.
  • Imported fully automatic synthesizer
    Each peptide synthesis process requires a strict quality control process, strict operating procedures and management system to ensure high-quality and efficient peptide production.
    Large scale automatic purification platform
    Fully utilize technological advantages to ensure high-quality and fast delivery of peptides. The independently developed advanced synthesis platform collaborates with the quality inspection system to provide customers with satisfactory products.
    Complex peptide synthesis platform
    Integrating advanced fully automated synthesis workstations, KS-V Peptide achieves precise and automated control in peptide library synthesis, achieving high-speed and flexible high-throughput peptide library synthesis.
  • Discovery of Emerging Compounds (HIT)
    Gene Protein Structure Analysis Resident Display Technology for Cyclic Peptide Library DEL+OBOC Combination Peptide Library Artificial Intelligence
    IND registration declaration
    Pharmacology, Pharmacodynamics, Toxicology Clinical Plan
    Preclinical research
    In vivo evaluation of non GLP pre toxicity (efficacy, pharmacokinetics)
    Optimization of chemical synthesis of lead compound
    SPR electrophysiological structure-activity relationship optimization ADMET, PK, CRISPR-Cas, Herg preliminary efficacy
    Lead compound discovery (LEAD)
    Chemical synthesis, structural drug design, multiple functional detection (electrophysiology, GPCR/FCS, FLIPR, etc.)
  • More precise
    KS-V Peptide has a mature packaging and shipping system to ensure the stability of peptide products as much as possible and prevent changes in peptide composition caused by oxidation and deliquescence.
    Extend storage time
    KS-V Peptide fully considers customers and provides customized peptides for all customers. In the production process, it adds more protective barriers to your peptide samples, avoids external environmental interference, and slows down peptide degradation.
    Save time and budget
    A longer shelf life can facilitate you to order a larger number of peptides at once, shorten the delivery cycle, and save additional transportation costs.
R&D TEAM AND TECHNOLOGY
  • Our team

  • Process platform

  • Service

  • Packaging technology

  • More than 30 PhD level research and development team KS-V Peptide has a doctoral-level R&D team of more than 30 people. The team members are from pharmaceutical companies and have many years of experience in drug development.
    Many years of service experience in peptide synthesis The management team has rich experience in innovative drug research and development and technical services, and has many years of experience in peptide synthesis services to assist in the preparation and process development of difficult peptides.
    More than 10 years of experience in polypeptide drug process development The team has more than 10 years of experience in peptide drug process development to ensure the economy, robustness and repeatability of the process.
  • Imported fully automatic synthesizer Each peptide synthesis process requires a strict quality control process, strict operating procedures and management system to ensure high-quality and efficient peptide production.
    Large scale automatic purification platform Fully utilize technological advantages to ensure high-quality and fast delivery of peptides. The independently developed advanced synthesis platform collaborates with the quality inspection system to provide customers with satisfactory products.
    Complex peptide synthesis platform Integrating advanced fully automated synthesis workstations, KS-V Peptide achieves precise and automated control in peptide library synthesis, achieving high-speed and flexible high-throughput peptide library synthesis.
  • Discovery of Emerging Compounds (HIT) Gene Protein Structure Analysis Resident Display Technology for Cyclic Peptide Library DEL+OBOC Combination Peptide Library Artificial Intelligence
    IND registration declaration Pharmacology, Pharmacodynamics, Toxicology Clinical Plan
    Preclinical research In vivo evaluation of non GLP pre toxicity (efficacy, pharmacokinetics)
    Optimization of chemical synthesis of lead compound SPR electrophysiological structure-activity relationship optimization ADMET, PK, CRISPR-Cas, Herg preliminary efficacy
    Lead compound discovery (LEAD) Chemical synthesis, structural drug design, multiple functional detection (electrophysiology, GPCR/FCS, FLIPR, etc.)
  • More precise KS-V Peptide has a mature packaging and shipping system to ensure the stability of peptide products as much as possible and prevent changes in peptide composition caused by oxidation and deliquescence.
    Extend storage time KS-V Peptide fully considers customers and provides customized peptides for all customers. In the production process, it adds more protective barriers to your peptide samples, avoids external environmental interference, and slows down peptide degradation.
    Save time and budget A longer shelf life can facilitate you to order a larger number of peptides at once, shorten the delivery cycle, and save additional transportation costs.
KPDS tm
KS-V Peptide Discovery Services
KPDS tm
KS-V Peptide Discovery Services
MEDIA CENTER
MEDIA CENTER
You can contact us at anytime!